Global Community

Red 5’s story hinges on a simple bet: if gold prices climb and the Sugar Zone project adds new output, the company’s cash generation could rise sharply. The catch is that the upside depends on hitting production targets and keeping costs under control as it scales.Read more

For years, Triodos Bank has been judged less like a bank and more like a market structure problem. Investors have been fixated on limited tradability, the depository receipt structure, and the credibility damage left by the suspension of trading in earlier years.Read more

Salazar Resources has a built-in advantage most tiny miners don’t: a larger partner pays to build its main mine, while Salazar keeps a slice of the upside. If the mine starts on time and Ecuador stays supportive, the share could re-rate sharply—but delays, politics, and future share issuance could still hit returns.Read more

Lotus Tech is teaming up with a tokenization platform and a cross-border payments provider to see if buyers can pay for luxury vehicles using regulated digital-asset payment rails. If it works, it could open up a new way to reach customers—but it also depends on getting real partnerships and compliance details over the line.Read more

AECOM's Q3 tells a story of two businesses at once: a headline quarter hit by a $337 million project charge, and an underlying infrastructure business that is still winning work at a record pace. The distinction is important.Read more

This Indonesian offshore vessel operator swings with oil and gas activity, and it has already shown how quickly profits can snap back when more ships are working. The catch is recent results turn down again, so the next few quarters decide whether this is a real recovery or just a one-off.Read more

The market is not debating whether Meta still has a strong business. It clearly does.Read more

A Novo Nordisk é uma máquina de qualidade excecional (ROA de 23%, quase sem goodwill, 11% de crescimento composto durante uma década) a atravessar uma compressão de preços nos EUA que o mercado está a tratar como permanente — paga hoje 11x lucros, contra mais de 40x em 2021. tenho a ideia de que o número de doentes tratados no Ocidente multiplica por cinco ou seis até 2033, à medida que a Europa, o Canadá e a Austrália criam regimes de comparticipação — Portugal, com 2 milhões de adultos obesos e o decreto do Infarmed em preparação, é um exemplo entre muitos.Read more

SIPEF is seeing a clear pickup in output and profits as its plantations become more productive and demand for palm oil gets a lift from biofuel policies. The big question is whether weather swings, politics, and rising input costs could derail what looks like a strong run.Read more